Articles
2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
Banach M, Surma S, Toth PP; endorsed by the International Lipid Expert Panel (ILEP)
Journal:
Arch Med Sci
First published: November 2, 2023 DOI: 10.5114/aoms/174743